Duligotuzumab Biosimilar - Research Grade

Human

ERBB3ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P21860

Blue ice

HER3 (ERBB3) is a catalytically impaired receptor tyrosine kinase that heterodimerizes with other ErbB receptors to drive oncogenic signaling, making it a compelling target in tumor biology research. This anti-human HER3 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of duligotuzumab, offered strictly for research use only (RUO). Built to demanding in vivo standards, the low-endotoxin, highly purified preparation is manufactured in scalable milligram (mg) to gram (g) quantities for heavy-usage, high-throughput laboratories. It serves as a dependable reference and blocking reagent across in vitro receptor screening, signaling-pathway studies, and in vivo oncology models.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks